article thumbnail

Understanding the 2025 Medicare Part D Re-design: What You Need to Know

Innovaare Compliance

The Prescription Drug Program, commonly known as Medicare Part D, is undergoing significant transformations in 2025 due to the Inflation Reduction Act (IRA) of 2022. Medicare Part D will have three (3) phases instead of four (4) – Deductible, Initial Coverage Phase and Catastrophic Phase. generics) in the catastrophic phase.

article thumbnail

Health Provider News

Hall Render

Ransomware attacks against hospitals put patients’ lives at risk, researchers say States, FTC continue to target noncompetes: 3 updates The best hospital in each state, per Newsweek What to know about Stark law’s $9.2M with historic building purchase MICHIGAN Bronson raises capital campaign goal to $4.5M

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthcare Reforms Under the IRA: Expanding Access to Care

Healthcare Law Blog

The expansive legislation includes key health care provisions, including drug pricing reforms, inflationary rebates, Medicare Part D benefit redesign, as well as myriad other updates. Medicare Drug Price Negotiation Program. The Inflation Reduction Act (“IRA”) was signed into law by President Biden on August 16, 2022.

article thumbnail

Health Provider News

Hall Render

million Staff shortages hit Medicare Advantage stars, Kaiser exec says Sutter Health slips to 0.1% million Staff shortages hit Medicare Advantage stars, Kaiser exec says Sutter Health slips to 0.1% million patients stolen during ransomware attack MINNESOTA CFO of the Year 2023: Penny Cermak, HealthPartners Inc.

article thumbnail

How Soon Could President Biden Enable Generic Competition to Xtandi? Very Quickly, If There Is the Will.

Bill of Health

As bad as this seems, it is worth noting that the patents run through 2027, and the FDA has already given tentative approval to two generic versions of enzalutamide. In 2021, the Medicare program spent nearly $7 million per day on Xtandi, or $2.4 billion in one year , and this does not include the non-Medicare sales in the U.S.,

Licensing 261
article thumbnail

Health Provider News

Hall Render

area to watch in 2024 DELAWARE Bayhealth now requires masks at hospitals, healthcare practices ChristianaCare drops top rated Medicare Advantage insurer. NATIONAL 60% of health systems considering ASC joint ventures 9% of hospitals had ‘vulnerable’ cash on hand levels in 2022 $3.7B region hard Development projects in the D.C.